Peart Akindele, Nadine A.
Katamoni, Laharika Dasharath
Brockhurst, Jacqueline
Ghimire, Shristi
Suwanmanee, San
Pieterse, Lisa
Metcalf Pate, Kelly A.
Bunyan, Elaine
Bannister, Roy
Cihlar, Tomas
Porter, Danielle P.
Griffin, Diane E.
Funding for this research was provided by:
National Institutes of Health (T32 AI052071, T32 OD011089, R01 AI153140)
Bauernschmidt Committee of Johns Hopkins School of Medicine
Chulabhorn Royal Academy
Gilead Sciences
Article History
Received: 5 December 2022
Accepted: 14 April 2023
First Online: 20 April 2023
Competing interests
: EB, DPP, RB and TC are employees of Gilead Sciences; DEG is a consultant for Merck and a member of the GSK Vaccines Research and Development Advisory Board, the Takeda Pharmaceuticals Zika virus Vaccine Data Monitoring Committee and GreenLight Biosciences Vaccine Development Scientific Advisory Board. NPA, LDK, JB, LP, SS, SG and KAMP declare no competing interests.